Informações:
Falhas:
ID
23085
Descrição
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00654576
Link
https://clinicaltrials.gov/show/NCT00654576
Palavras-chave
Versões (1)
- 22/06/2017 22/06/2017 -
Transferido a
22 de junho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Schizophrenia NCT00654576
Eligibility Schizophrenia NCT00654576
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00654576
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
eligible patients were 16 to 50 years of age;
boolean
C0001779 (UMLS CUI [1])
Schizophrenia
Item
had received a diagnosed of schizophrenia in accordance with criteria set out in the diagnostic and statistical manual of mental disorders-fourth edition (dsm-iv);
boolean
C0036341 (UMLS CUI [1])
PANSS Stable status Clinical | PANSS Decrease Percentage
Item
were confirmed to be clinically stable by the investigator (the total score ≤60 on the positive and negative syndrome scale [panss] or a decrease of fifty percent from acute period in the total score on panss)
boolean
C0451383 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0451383 (UMLS CUI [2,1])
C0547047 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
C0205360 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0451383 (UMLS CUI [2,1])
C0547047 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Oral antipsychotic therapy Maintenance
Item
and taken maintenance treatment with any one of the following seven oral antipsychotics:
boolean
C4273790 (UMLS CUI [1,1])
C0024501 (UMLS CUI [1,2])
C0024501 (UMLS CUI [1,2])
Chlorpromazine
Item
chlorpromazine
boolean
C0008286 (UMLS CUI [1])
Sulpiride | Clozapine
Item
sulpiride clozapine
boolean
C0038803 (UMLS CUI [1])
C0009079 (UMLS CUI [2])
C0009079 (UMLS CUI [2])
Risperidone
Item
risperidone
boolean
C0073393 (UMLS CUI [1])
olanzapine
Item
olanzapine
boolean
C0171023 (UMLS CUI [1])
quetiapine
Item
quetiapine
boolean
C0123091 (UMLS CUI [1])
aripiprazole
Item
aripiprazole
boolean
C0299792 (UMLS CUI [1])
Schizoaffective Disorder | Mental Retardation | Cognition Disorders
Item
patients were excluded if they had received a diagnosis of schizoaffective disorder, mental retardation, or other cognitive disorders;
boolean
C0036337 (UMLS CUI [1])
C0025362 (UMLS CUI [2])
C0009241 (UMLS CUI [3])
C0025362 (UMLS CUI [2])
C0009241 (UMLS CUI [3])
Adverse reactions Serious
Item
had a history of serious adverse reactions to the proposed treatment;
boolean
C0559546 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Pregnancy | Breast Feeding | Medical condition Serious Unstable
Item
were pregnant or breastfeeding; or had a serious and unstable medical condition.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3843040 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0443343 (UMLS CUI [3,3])
C0006147 (UMLS CUI [2])
C3843040 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0443343 (UMLS CUI [3,3])
Informed Consent Unable
Item
patients were excluded if they were unable to provide informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])